During the past decade, Sanbo Brain Hospital Capital Medical University conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanbo Brain Hospital Capital Medical University" #1 sponsor was "Beijing Sanbo Brain Hospital" with 9 trials, followed by "Denovo Biopharma LLC" with 1 trials sponsored, "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Peking Union Medical College Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanbo Brain Hospital Capital Medical University" #1 collaborator was "Marino Biotechnology Co., Ltd." with 2 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator and "Capital Medical University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sanbo Brain Hospital Capital Medical University" are "Glioblastoma" (2 trials), "Glioblastoma Multiforme" (2 trials), "Primary Central Nervous System Lymphoma" (2 trials), "Alzheimer Disease" (1 trials) and "Drug Resistant Epilepsy" (1 trials). Many other conditions were trialed in "Sanbo Brain Hospital Capital Medical University" in a lesser frequency.

Most popular intervention types in "Sanbo Brain Hospital Capital Medical University" are "Drug" (11 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (2 trials), "Anti-PD-L1 CSR T cells" (1 trials), "Apatinib Combined With Temozolomide and Etoposide Capsules" (1 trials), "Camrelizumab" (1 trials) and "Camrelizumab and Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanbo Brain Hospital Capital Medical University" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Sanbo Brain Hospital Capital Medical University". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sanbo Brain Hospital Capital Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanbo Brain Hospital Capital Medical University, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".